For the first time in over twenty years, a new home-use treatment for female hair loss is available. Lexington Intl, LLC, is excited to announce they have received historic and groundbreaking FDA Clearance for marketing for the HairMax LaserComb® Lux 9 to treat female hair loss and promote hair growth. Included as a key part of the submission was a multi-center clinical study proving the efficacy and safety of the HairMax.
“Hair loss amongst women is a growing concern”, says Dr. Matt Leavitt, Medical Advisor to Lexington. “In the past, women had only one FDA Approved drug ingredient to treat their hair loss. Now they have a clinically proven viable alternative. Upon review of Lexington’s extensive clinical studies on female hair loss, the FDA has granted Clearance to this exciting new treatment option. I believe the HairMax will be able to offer help to the millions of women suffering from hair loss.”
The last hair loss treatment for women to be approved by the FDA was minoxidil, which came to market for females in 1988. The HairMax is now the first non-drug, home-use OTC medical device cleared to treat the estimated 80 million men and women suffering from hereditary hair loss.
